10 days ago
BBIO
Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
---|---|---|---|---|---|
Longboard Pharmaceuticals IncLBPH | +305.80% | $5.17 | $20.98 | 2023-10-23 - 2024-03-27 | Strong Buy |
Longboard Pharmaceuticals IncLBPH | +280.07% | $5.52 | $20.98 | 2023-12-19 - 2024-03-27 | Strong Buy |
Longboard Pharmaceuticals IncLBPH | +271.99% | $5.64 | $20.98 | 2023-12-18 - 2024-03-27 | Strong Buy |
4d Molecular Therapeutics IncFDMT | +240.97% | $10.52 | $35.87 | 2023-10-23 - 2024-03-27 | Strong Buy |
Voyager Therapeutics IncVYGR | +183.31% | $8.57 | $24.28 | 2017-08-16 - 2018-03-12 | Buy |
Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
---|---|---|---|---|---|---|
Cabaletta Bio IncCABA | 3 | Strong Buy | $50.00 | +191.55% | Reiterates | 6 days ago |
Janux Therapeutics IncJANX | 1 | Strong Buy | $100.00 | +163.71% | Initiates Coverage On | 9 days ago |
Bridgebio Pharma IncBBIO | 5 | Strong Buy | $70.00 | +126.83% | Maintains | 10 days ago |
Longboard Pharmaceuticals IncLBPH | 7 | Strong Buy | $60.00 | +185.99% | Reiterates | 16 days ago |
Crinetics Pharmaceuticals IncCRNX | 4 | Strong Buy | $65.00 | +46.30% | Maintains | 25 days ago |
Mirum Pharmaceuticals IncMIRM | 5 | Strong Buy | $40.00 | +59.24% | Maintains | 25 days ago |
Rocket Pharmaceuticals IncRCKT | 3 | Strong Buy | $65.00 | +138.53% | Maintains | a month ago |
Cg Oncology IncCGON | 1 | Strong Buy | $75.00 | +82.93% | Initiates Coverage On | a month ago |
Rallybio CorpRLYB | 2 | Buy | $15.00 | +843.40% | Maintains | 3 months ago |
Krystal Biotech IncKRYS | 3 | Strong Buy | $180.00 | +1.58% | Maintains | 4 months ago |
Ventyx Biosciences IncVTYX | 2 | Hold | $5.00 | -13.87% | Downgrades | 5 months ago |
4d Molecular Therapeutics IncFDMT | 1 | Strong Buy | $32.00 | -10.79% | Initiates Coverage On | 5 months ago |
Insmed IncINSM | 2 | Buy | $42.00 | +53.73% | Maintains | 7 months ago |
Otis Worldwide CorpOTIS | 4 | Hold | $92.00 | -7.87% | Maintains | 8 months ago |
Chinook Therapeutics IncKDNY | 1 | Hold | $40.00 | -0.97% | Downgrades | 9 months ago |
Erasca IncERAS | 2 | Buy | $11.00 | +433.98% | Maintains | 10 months ago |
Avidity Biosciences IncRNA | 3 | Buy | $20.00 | -18.93% | Upgrades | 10 months ago |
Bellus Health IncBLU | 3 | Hold | $14.75 | +0.07% | Downgrades | a year ago |
Atreca IncBCEL | 1 | Hold | $1.50 | +900.00% | Downgrades | a year ago |
Seagen IncSGEN | 1 | Hold | $229.00 | N/A | Downgrades | a year ago |
Bionomics LimitedBNOX | 2 | Buy | $6.00 | N/A | Upgrades | a year ago |
Neurocrine Biosciences IncNBIX | 2 | Buy | $130.00 | N/A | Upgrades | a year ago |
Denali Therapeutics IncDNLI | 3 | Buy | $50.00 | N/A | Maintains | a year ago |
Tg Therapeutics IncTGTX | 3 | Buy | $25.00 | N/A | Maintains | a year ago |
Myovant Sciences LtdMYOV | 3 | Hold | $27.00 | N/A | Downgrades | a year ago |
Regeneron Pharmaceuticals IncREGN | 3 | Hold | $760.00 | N/A | Downgrades | a year ago |
Spero Therapeutics IncSPRO | 3 | Buy | $8.00 | N/A | Upgrades | 2 years ago |
Zymeworks IncZYME | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 2 years ago |
Icosavax IncICVX | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 3 years ago |
Tourmaline Bio IncTRML | 1 | Buy | $35.00 | N/A | Initiates Coverage On | 3 years ago |
Viracta Therapeutics IncVIRX | 1 | Buy | $45.00 | N/A | Initiates Coverage On | 3 years ago |
Biomarin Pharmaceutical IncBMRN | 2 | Buy | $100.00 | N/A | Upgrades | 3 years ago |
Cullinan Oncology IncCGEM | 1 | Buy | $55.00 | N/A | Initiates Coverage On | 3 years ago |
Beyondspring IncBYSI | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
Freeline Therapeutics Holdings PLCFRLN | 1 | Buy | $480.00 | N/A | Initiates Coverage On | 4 years ago |
Cymabay Therapeutics IncCBAY | 1 | Buy | $15.00 | N/A | Upgrades | 4 years ago |
Bluebird Bio IncBLUE | 4 | Buy | $100.00 | N/A | Upgrades | 4 years ago |
Regenxbio IncRGNX | 3 | Buy | N/A | N/A | Upgrades | 5 years ago |
Madrigal Pharmaceuticals IncMDGL | 2 | Buy | $250.00 | N/A | Upgrades | 5 years ago |
Shire PLCSHPG | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Incyte CorpINCY | 3 | Strong Buy | $85.00 | N/A | Assumes | 6 years ago |
Ionis Pharmaceuticals IncIONS | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Voyager Therapeutics IncVYGR | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Bioverativ IncBIVV | 3 | Hold | N/A | N/A | Downgrades | 6 years ago |
Uniqure NvQURE | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 6 years ago |
Adamas Pharmaceuticals IncADMS | 1 | Buy | $85.00 | N/A | Initiates Coverage On | 6 years ago |
Audentes Therapeutics IncBOLD | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Theravance Biopharma IncTBPH | 1 | Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Spark Therapeutics IncONCE | 1 | Hold | $83.00 | N/A | Initiates Coverage On | 7 years ago |
Avexis IncAVXS | 1 | Buy | $120.00 | N/A | Initiates Coverage On | 7 years ago |
Abbvie IncABBV | 1 | Buy | $95.00 | N/A | Initiates Coverage On | 7 years ago |